US Stock MarketDetailed Quotes
LVCLY ALGORAE PHARMACEUTICALS LTD SPON ADR EA REPR 10 ORD NPV
- 0.042680
- 0.0000000.00%
15min DelayClose Apr 24 16:00 ET
7.20MMarket Cap-4268P/E (TTM)
0.000000High0.000000Low0Volume0.042680Open0.042680Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)168.64MShares0.08350052wk High3.05P/B7.20MFloat Cap0.02100052wk Low--Dividend TTM168.64MShs Float0.119300Historical High--Div YieldTTM0.00%Amplitude0.021000Historical Low--Avg Price1Lot Size
ALGORAE PHARMACEUTICALS LTD SPON ADR EA REPR 10 ORD NPV Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | (FY)Jun 30, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -67.57%3.17K | -91.95%9.77K | 5.31%121.4K | -4.01%115.28K | -80.38%120.09K | -91.72%611.96K | -2.45%7.39M | |||
| Operating revenue | ---- | ---- | ---- | -67.57%3.17K | -91.95%9.77K | 5.31%121.4K | -4.01%115.28K | -80.38%120.09K | -91.72%611.96K | -2.45%7.39M |
| Cost of revenue | -81.09%109.99K | -91.42%581.58K | -4.13%6.78M | |||||||
| Gross profit | -67.57%3.17K | -91.95%9.77K | 5.31%121.4K | 1,040.92%115.28K | -66.74%10.1K | -95.09%30.38K | 20.59%618.64K | |||
| Operating expense | -10.38%2.13M | 4.08%2.38M | -27.87%2.28M | -24.12%3.17M | -5.01%4.17M | -18.18%4.39M | 32.66%5.37M | 21.88%4.05M | 50.84%3.32M | 32.20%2.2M |
| Selling and administrative expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5.87%1.63M | -9.65%1.54M | 35.12%1.71M |
| -General and administrative expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5.87%1.63M | -9.65%1.54M | 35.12%1.71M |
| Research and development costs | -10.49%1.31M | -9.08%1.46M | -32.49%1.61M | -28.39%2.38M | -4.95%3.33M | -21.15%3.5M | 87.86%4.44M | 33.26%2.36M | 264.08%1.77M | 23.07%487.36K |
| Depreciation amortization depletion | -25.03%557 | -84.45%743 | -71.65%4.78K | -67.78%16.85K | -15.74%52.3K | -17.37%62.07K | 51.75%75.12K | 1,198.56%49.5K | -46.54%3.81K | 18.85%7.13K |
| -Depreciation and amortization | -25.03%557 | -84.45%743 | -71.65%4.78K | -67.78%16.85K | -15.74%52.3K | -17.37%62.07K | 51.75%75.12K | 1,198.56%49.5K | -46.54%3.81K | 18.85%7.13K |
| Other operating expenses | -10.19%819.89K | 36.34%912.92K | -12.51%669.61K | -3.23%765.32K | -4.44%790.89K | -2.73%827.65K | --850.85K | ---- | ---36 | ---- |
| Operating profit | 10.38%-2.13M | -4.08%-2.38M | 27.80%-2.28M | 24.01%-3.16M | 2.54%-4.16M | 18.69%-4.27M | -30.13%-5.25M | -22.69%-4.04M | -107.88%-3.29M | -37.36%-1.58M |
| Net non-operating interest income expense | 1,133.95%42.02K | -55.20%3.41K | -86.33%7.6K | -54.88%55.61K | -17.54%123.25K | 5.15%149.48K | 15.42%142.16K | -37.23%123.17K | -3.45%196.21K | 42.11%203.22K |
| Non-operating interest income | 1,133.95%42.02K | -55.20%3.41K | -86.33%7.6K | -54.88%55.61K | -17.54%123.25K | 5.15%149.48K | 15.42%142.16K | -39.53%123.17K | -5.85%203.69K | 40.49%216.35K |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -43.05%7.48K | 19.34%13.13K |
| Other net income (expense) | -3,360.10%-20.18K | -99.83%619 | -79.04%365.79K | 242.65%1.74M | -85.38%509.26K | 326.71%3.48M | 5.95%816.22K | 119.48%770.37K | 26.87%-3.95M | -173.62%-5.41M |
| Earnings from equity interest | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.34%-67.36K | 31.82%-4.07M | -20.11%-5.96M |
| Special income (charges) | ---- | ---12.31K | ---- | ---148.2K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---12.31K | ---- | ---148.2K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | -256.12%-20.18K | -96.47%12.93K | -80.68%365.79K | 271.75%1.89M | -85.38%509.26K | 326.71%3.48M | -2.57%816.22K | 647.33%837.73K | -79.86%112.1K | -81.38%556.46K |
| Income before tax | 11.15%-2.11M | -24.49%-2.37M | -41.63%-1.91M | 61.31%-1.35M | -503.43%-3.48M | 86.34%-576.29K | -36.40%-4.22M | 56.08%-3.09M | -3.90%-7.04M | -127.56%-6.78M |
| Income tax | 0 | 6.77%-414.73K | -18.02%-444.86K | -27.27%-376.92K | -46.75%-296.15K | -56.81%-201.8K | -128.69K | 0 | 0 | 0 |
| Net income | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | -749.51%-3.18M | 90.84%-374.49K | -32.24%-4.09M | 56.08%-3.09M | -3.90%-7.04M | -127.56%-6.78M |
| Net income continuous Operations | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | -749.51%-3.18M | 90.84%-374.49K | -32.24%-4.09M | 56.08%-3.09M | -3.90%-7.04M | -127.56%-6.78M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | -749.51%-3.18M | 90.84%-374.49K | -32.24%-4.09M | 56.08%-3.09M | -3.90%-7.04M | -127.56%-6.78M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -7.68%-2.11M | -34.01%-1.96M | -50.81%-1.46M | 69.56%-968.47K | -749.51%-3.18M | 90.84%-374.49K | -32.24%-4.09M | 56.08%-3.09M | -3.90%-7.04M | -127.56%-6.78M |
| Basic earnings per share | 26.36%-0.016 | 11.45%-0.0217 | -52.94%-0.0245 | 69.64%-0.016 | -700.03%-0.0529 | 90.90%-0.0066 | -10.15%-0.0726 | 60.57%-0.0659 | 7.89%-0.1672 | -128.92%-0.1816 |
| Diluted earnings per share | 26.36%-0.016 | 11.45%-0.0217 | -52.94%-0.0245 | 69.64%-0.016 | -700.03%-0.0529 | 90.90%-0.0066 | -10.15%-0.0726 | 60.57%-0.0659 | 7.89%-0.1672 | -128.92%-0.1816 |
| Dividend per share | ||||||||||
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg